Hepatitis B Topics HBV Treatment
Coverage of the 2012 AASLD Liver Meeting
- Details
- Category: HBV Treatment
- Published on Tuesday, 13 November 2012 00:00
- Written by Liz Highleyman
HIVandHepatitis.com coverage of the 63rd Annual Meeting of the American Association for the Study of Liver Diseases (AASLD 2012) in Boston, November 9-13, 2012.
Conference highlights include treatment for hepatitis B and C, new direct-acting HCV drugs, interferon-free hepatitis C therapy, management of liver disease complications, HIV/HBV and HIV/HCV coinfection, and prevention and treatment of hepatocellular carcioma.
HIVandHepatitis.com AASLD 2012 conference section
Antiviral Therapy Safe and Effective for Hep B Patients with Advanced Cirrhosis
- Details
- Category: HBV Treatment
- Published on Tuesday, 06 November 2012 00:00
- Written by Liz Highleyman
Antiviral drugs including entecavir (Baraclude), lamivudine (Epivir-HBV), telbivudine (Tyzeka), and tenofovir (Viread) are generally well-tolerated and effective against hepatitis B virus (HBV) in people with liver cirrhosis, and may lower mortality even among patients with severe decompensated cirrhosis, according to 2 recently published studies.
Resources for People with HIV and Hepatitis and Providers in Disaster Areas
- Details
- Category: HIV Treatment
- Published on Tuesday, 30 October 2012 00:00
- Written by Liz Highleyman
During disasters such as Hurricane Sandy, people with chronic medical conditions including HIV and viral hepatitis will be among those displaced and requiring emergency care. Government agencies offer a number of resources for people with these and other chronic conditions, healthcare providers, and others who provide emergency and disaster-related services.
[Editor's note: This resource list will be updated as further information becomes available.]
Registry Data Show Hepatitis B Medications Appear Safe during Pregnancy
- Details
- Category: HBV Treatment
- Published on Tuesday, 30 October 2012 00:00
- Written by Liz Highleyman
An analysis of data from the Antiretroviral Pregnancy Registry found no evidence that pregnant women's use of drugs to treat chronic hepatitis B -- including lamivudine (Epivir) and tenofovir (Viread) -- is associated with birth defects, according to a report in the November 2012 Journal of Hepatology. 
Hepatitis B Patients with HBeAg Seroconversion on Treatment May Not Have Durable Response
- Details
- Category: HBV Treatment
- Published on Tuesday, 23 October 2012 00:00
- Written by Liz Highleyman
People with chronic hepatitis B virus (HBV) who achieve hepatitis B "e" antigen (HBeAg) seroconversion when treated with nucleoside/nucleotide analogs are more likely to experience HBeAg seroreversion and HBV reactivation than those with natural clearance, according to a study described in the November 15, 2012, Journal of Infectious Diseases.
More Articles...
- Entecavir (Baraclude) Label Adds Data on Black Patients and Liver Transplant Recipients with HBV
- Entecavir Alone Works as Well as Combo for First-time Hepatitis B Treatment
- Adefovir-resistant Hepatitis B Virus Can Remain Susceptible to Tenofovir
- Heavy Alcohol Use Impairs Biochemical Response to Entecavir for Chronic Hepatitis B
Web Design and Development by